000 01401 a2200361 4500
005 20250513150932.0
264 0 _c19981117
008 199811s 0 0 eng d
022 _a0268-3369
024 7 _a10.1038/sj.bmt.1701307
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKatsanis, E
245 0 0 _aActivated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma.
_h[electronic resource]
260 _bBone marrow transplantation
_cJul 1998
300 _a185-91 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAnimals
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
650 0 4 _aInterleukin-2
_xadministration & dosage
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aLymphoma, B-Cell
_xblood
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aNeoplasms, Experimental
_ximmunology
650 0 4 _aTransplantation, Autologous
700 1 _aWeisdorf, D J
700 1 _aMiller, J S
773 0 _tBone marrow transplantation
_gvol. 22
_gno. 2
_gp. 185-91
856 4 0 _uhttps://doi.org/10.1038/sj.bmt.1701307
_zAvailable from publisher's website
999 _c9672621
_d9672621